Lipids

John P. Kastelein in conversation with Ulf LandmesserEpidemiology of HDL . (Feb 2011)

Stephen Nicholls in conversation with Ulf LandmesserResults of the First Major Clinical Trial of an Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CVR Risk Modification. (Nov 2010)